{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:24:55Z","timestamp":1649067895208},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T00:00:00Z","timestamp":1345680000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s12024-012-9373-7","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T06:06:16Z","timestamp":1345615576000},"page":"73-76","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation"],"prefix":"10.1007","volume":"9","author":[{"given":"Jineane V.","family":"Venci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan M.","family":"Rowcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Rainka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran M.","family":"Gengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,23]]},"reference":[{"key":"9373_CR1","unstructured":"Product Information: TEGRETOL(R) chewable oral tablets, oral tablets, oral suspension, TEGRETOL(R) XR extended-release oral tablets, carbamazepine chewable oral tablets, oral tablets, oral suspension, extended-release oral tablets. In: Corporation NP, editor. East Hanover, NJ; 2003."},{"key":"9373_CR2","unstructured":"Product Information: EQUETRO(TM) oral extended release capsules, carbamazepine oral extended release capsules. In: Inc SU, editor. Wayne, PA; 2004."},{"key":"9373_CR3","first-page":"177","volume-title":"Basic clinical pharmacokentics","author":"W Me","year":"1994","unstructured":"Me W. Carbamazepine. In: Koda-Kimble MA, editor. Basic clinical pharmacokentics. 3rd ed. Vancouver: Applied Therapeutics; 1994. p. 177\u201384.","edition":"3"},{"issue":"6","key":"9373_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2007-979609","volume":"28","author":"F Albani","year":"1995","unstructured":"Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: a review. Pharmacopsychiatry. 1995;28(6):235\u201344.","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"9373_CR5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199529040-00005","volume":"29","author":"D Battino","year":"1995","unstructured":"Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet. 1995;29(4):257\u201386.","journal-title":"Clin Pharmacokinet"},{"key":"9373_CR6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/106002809302700605","volume":"27","author":"DJ Chapron","year":"1993","unstructured":"Chapron DJ, LaPierre BA, Abou-Elkair M. Unmasking the significant enzyme inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal. Ann Pharmacother. 1993;27:708\u201311.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"9373_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1528-1157.1991.tb05620.x","volume":"31","author":"JS Duncan","year":"1991","unstructured":"Duncan JS, Patsalos PN, Shorvon SD. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication. Epilepsia. 1991;31(1):101\u201315.","journal-title":"Epilepsia"},{"issue":"6","key":"9373_CR8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2165\/00003088-199631060-00005","volume":"31","author":"R Riva","year":"1996","unstructured":"Riva R, Albani F, Contin M, Baruzzi A. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet. 1996;31(6):470\u201393.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"9373_CR9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","volume":"31","author":"E Spina","year":"1996","unstructured":"Spina E, Pisani F, Perucca E. Clinically significant pharmacokinetic interactions with carbamazepine. An update. Clin Pharmacokinet. 1996;31(3):198\u2013214.","journal-title":"Clin Pharmacokinet"},{"key":"9373_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00007691-198703000-00004","volume":"9","author":"JJ Zielinski","year":"1987","unstructured":"Zielinski JJ, Haidukewych D. Duel effects of carbamazepine-phenytoin interaction. Ther Drug Monit. 1987;9:21\u20133.","journal-title":"Ther Drug Monit"},{"key":"9373_CR11","volume-title":"ADAPT 5 user\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"DZ D\u2019Argenio","year":"2009","unstructured":"D\u2019Argenio DZ, Schumitzky A, Wang X. ADAPT 5 user\u2019s guide: pharmacokinetic\/pharmacodynamic systems analysis software. Los Angeles: Biomedical Simulations Resource; 2009."},{"issue":"3","key":"9373_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2710.2001.00348.x","volume":"26","author":"IB Bondareva","year":"2001","unstructured":"Bondareva IB, Sokolov AV, Tischenkova IF, Jelliffe RW. Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage. J Clin Pharm Ther. 2001;26(3):213\u201323.","journal-title":"J Clin Pharm Ther"},{"key":"9373_CR13","first-page":"483","volume-title":"Antiepileptic drugs","author":"JW Faigle","year":"1982","unstructured":"Faigle JW, Feldmann FK. Carbamazepine: biotransformation. In: Woodbury DM, Pippenger CE, editors. Antiepileptic drugs. New York: Raven Press; 1982. p. 483\u201395."},{"issue":"6","key":"9373_CR14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/bdd.2510130604","volume":"13","author":"J Bonneton","year":"1992","unstructured":"Bonneton J, Genton P, Mesdjian E. Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients. Biopharm Drug Dispos. 1992;13(6):411\u20136.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"9373_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0920-1211(98)00071-0","volume":"33","author":"T May","year":"1999","unstructured":"May T, Jurgens U, Rambeck B, Schnabel R. Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10, 11-epoxide metabolite in institutionalized patients with epilepsy. Epilepsy Res. 1999;33(1):57\u201365.","journal-title":"Epilepsy Res"},{"issue":"6","key":"9373_CR16","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1520\/JFS15182J","volume":"46","author":"HA Spiller","year":"2001","unstructured":"Spiller HA, Carlisle RD. Timely antemortem and postmortem concentrations in a fatal carbamazepine overdose. J Forensic Sci. 2001;46(6):1510\u20132.","journal-title":"J Forensic Sci"},{"key":"9373_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.forsciint.2012.01.016","volume":"219","author":"E Han","year":"2012","unstructured":"Han E, Kim E, Hong H, Jeong S, Kim J, In S, et al. Evaluation of postmortem redistribution phenomena for commonly encountered drugs. Forensic Sci Int. 2012;219:265\u201371.","journal-title":"Forensic Sci Int"},{"issue":"3","key":"9373_CR18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/15563659309000413","volume":"31","author":"HA Spiller","year":"1993","unstructured":"Spiller HA, Krenzelok EP. Carbamazepine overdose: serum concentration less predictive in children. J Toxicol Clin Toxicol. 1993;31(3):459\u201360.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"4","key":"9373_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/15563659009038587","volume":"28","author":"HA Spiller","year":"1990","unstructured":"Spiller HA, Krenzelok EP, Cookson E. Carbamazepine overdose: a prospective study of serum levels and toxicity. J Toxicol Clin Toxicol. 1990;28(4):445\u201358.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"2","key":"9373_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3476(05)81208-9","volume":"121","author":"J Tibballs","year":"1992","unstructured":"Tibballs J. Acute toxic reaction to carbamazepine: clinical effects and serum concentrations. J Pediat. 1992;121(2):295\u20139.","journal-title":"J Pediat"},{"issue":"5","key":"9373_CR21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0196-0644(95)70175-3","volume":"25","author":"ES Stremski","year":"1995","unstructured":"Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbamazepine intoxication. Ann Emerg Med. 1995;25(5):624\u201330.","journal-title":"Ann Emerg Med"}],"container-title":["Forensic Science, Medicine, and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-012-9373-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-012-9373-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-012-9373-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:01:16Z","timestamp":1559426476000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-012-9373-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["9373"],"URL":"https:\/\/doi.org\/10.1007\/s12024-012-9373-7","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,23]]}}}